-Scroll.in Terms of agreement give private players 30-year lease over parts of government district hospitals. Niti Aayog and the Union ministry for health and family welfare have proposed a model contract to increase the role of private hospitals in treating non-communicable diseases in urban India. The agreement, which has been been shared with states for their comments, allows private hospitals to bid for 30-year leases over parts of district hospital buildings...

-Scroll.in Arsenic levels in water have been as high as 3,880 parts per billion in parts of the state. Pollution standards cite 50 parts per billion as harmful. It is a day like any other at Mahavir Cancer Sansthan. The driveway is lined with people who have travelled a long way to get to this charitable hospital in Patna. Families sit huddled, holding their bags close. The lobby is even more crowded,...

-The Times of India Cancer drugs, being the top focus for research and development, corner the lion's share of medicines launched globally, yet only a handful make it to developing countries like India. Only seven oncology drugs were introduced in India over five years (2010-2014), when nearly 50 breakthrough therapies were rolled out globally. The disparity in availability of oncology therapies becomes even more stark over a 10-year period (2006-2016), with not even...

-The Hindu Rise in cancer cases in Punjab can be attributed to indiscriminate use of agro-chemicals after the Green Revolution Bathinda: Lying on a bench at the Bathinda railway station, sexagenarian Gurjant Singh waits to board the Abohar-Jodhpur passenger train. He, however, is not the only one waiting. As the train chugs into the platform, people rush to claim their seats. Those who are unsuccessful settle down on the floor. Soon, the...

-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...